139 related articles for article (PubMed ID: 7805032)
1. Tumor suppressive role of an androgen-regulated epithelial cell adhesion molecule (C-CAM) in prostate carcinoma cell revealed by sense and antisense approaches.
Hsieh JT; Luo W; Song W; Wang Y; Kleinerman DI; Van NT; Lin SH
Cancer Res; 1995 Jan; 55(1):190-7. PubMed ID: 7805032
[TBL] [Abstract][Full Text] [Related]
2. Function and therapeutic implication of C-CAM cell-adhesion molecule in prostate cancer.
Lin SH; Pu YS
Semin Oncol; 1999 Apr; 26(2):227-33. PubMed ID: 10597733
[TBL] [Abstract][Full Text] [Related]
3. Suppression of human bladder cancer growth by increased expression of C-CAM1 gene in an orthotopic model.
Kleinerman DI; Dinney CP; Zhang WW; Lin SH; Van NT; Hsieh JT
Cancer Res; 1996 Aug; 56(15):3431-5. PubMed ID: 8758907
[TBL] [Abstract][Full Text] [Related]
4. Application of a tumor suppressor (C-CAM1)-expressing recombinant adenovirus in androgen-independent human prostate cancer therapy: a preclinical study.
Kleinerman DI; Zhang WW; Lin SH; Nguyen TV; von Eschenbach AC; Hsieh JT
Cancer Res; 1995 Jul; 55(13):2831-6. PubMed ID: 7796410
[TBL] [Abstract][Full Text] [Related]
5. Consistent expression of an epithelial cell adhesion molecule (C-CAM) during human prostate development and loss of expression in prostate cancer: implication as a tumor suppressor.
Kleinerman DI; Troncoso P; Lin SH; Pisters LL; Sherwood ER; Brooks T; von Eschenbach AC; Hsieh JT
Cancer Res; 1995 Mar; 55(6):1215-20. PubMed ID: 7533659
[TBL] [Abstract][Full Text] [Related]
6. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells.
Estrera VT; Luo W; Phan D; Earley K; Hixson DC; Lin SH
Biochem Biophys Res Commun; 1999 Oct; 263(3):797-803. PubMed ID: 10512760
[TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains.
Luo W; Wood CG; Earley K; Hung MC; Lin SH
Oncogene; 1997 Apr; 14(14):1697-704. PubMed ID: 9135071
[TBL] [Abstract][Full Text] [Related]
8. C-CAM1 expression: differential effects on morphology, differentiation state and suppression of human PC-3 prostate carcinoma cells.
Comegys MM; Carreiro MP; Brown JF; Mazzacua A; Flanagan DL; Makarovskiy A; Lin SH; Hixson DC
Oncogene; 1999 May; 18(21):3261-76. PubMed ID: 10359532
[TBL] [Abstract][Full Text] [Related]
9. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition.
Luo W; Earley K; Tantingco V; Hixson DC; Liang TC; Lin SH
Oncogene; 1998 Mar; 16(9):1141-7. PubMed ID: 9528856
[TBL] [Abstract][Full Text] [Related]
10. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
[TBL] [Abstract][Full Text] [Related]
11. Expression and androgen regulation of C-CAM cell adhesion molecule isoforms in rat dorsal and ventral prostate.
Makarovskiy AN; Pu YS; Lo P; Earley K; Paglia M; Hixson DC; Lin SH
Oncogene; 1999 May; 18(21):3252-60. PubMed ID: 10359531
[TBL] [Abstract][Full Text] [Related]
12. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L
Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775
[TBL] [Abstract][Full Text] [Related]
13. Schedule-dependence of C-CAM1 adenovirus gene therapy in a prostate cancer model.
Lin SH; Pu YS; Luo W; Wang Y; Logothetis CJ
Anticancer Res; 1999; 19(1A):337-40. PubMed ID: 10226564
[TBL] [Abstract][Full Text] [Related]
14. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth.
Turbide C; Kunath T; Daniels E; Beauchemin N
Cancer Res; 1997 Jul; 57(13):2781-8. PubMed ID: 9205090
[TBL] [Abstract][Full Text] [Related]
15. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice.
Zhang F; Lee J; Lu S; Pettaway CA; Dong Z
Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637
[TBL] [Abstract][Full Text] [Related]
16. Transfected neu oncogene induces human prostate cancer metastasis.
Zhau HY; Zhou J; Symmans WF; Chen BQ; Chang SM; Sikes RA; Chung LW
Prostate; 1996 Feb; 28(2):73-83. PubMed ID: 8604395
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer.
Inoue K; Slaton JW; Eve BY; Kim SJ; Perrotte P; Balbay MD; Yano S; Bar-Eli M; Radinsky R; Pettaway CA; Dinney CP
Clin Cancer Res; 2000 May; 6(5):2104-19. PubMed ID: 10815938
[TBL] [Abstract][Full Text] [Related]
18. Suppression of LNCaP prostate cancer xenograft tumors by a prostate-specific protein tyrosine phosphatase, prostatic acid phosphatase.
Igawa T; Lin FF; Rao P; Lin MF
Prostate; 2003 Jun; 55(4):247-58. PubMed ID: 12712404
[TBL] [Abstract][Full Text] [Related]
19. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice.
Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z
Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958
[TBL] [Abstract][Full Text] [Related]
20. Antisense human neuroglia related cell adhesion molecule hNr-CAM, reduces the tumorigenic properties of human glioblastoma cells.
Sehgal A; Ricks S; Warrick J; Boynton AL; Murphy GP
Anticancer Res; 1999; 19(6B):4947-53. PubMed ID: 10697494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
